Your prediction
Pros and Cons of Accelerate Diagnostics Inc. in the next few years
Pros
?
M***** P*******
?
C******** o* t** e**********
?
S********** s********
Cons
?
G***** c******* t* c**********
?
B****
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Accelerate Diagnostics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Accelerate Diagnostics Inc. | - | - | - | - | - | - | - |
| MicroVision Inc | 1.510% | 1.669% | -24.512% | -55.524% | -19.310% | -76.794% | -96.004% |
| Cytosorbents Corp. | 3.160% | -0.704% | -3.590% | -45.136% | -2.083% | -82.815% | -93.978% |
| Accuray Inc. | 1.860% | -33.846% | -43.046% | -80.631% | -37.226% | -85.162% | - |
Comments
Accelerate Diagnostics, Inc. (NASDAQ: AXDX) had its "outperform" rating re-affirmed by analysts at William Blair.
Show more
Ratings data for AXDX provided by MarketBeat
Accelerate Diagnostics, Inc. (NASDAQ: AXDX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Show more
Ratings data for AXDX provided by MarketBeat